Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 04 02:03PM ET
3.01
Dollar change
+0.06
Percentage change
2.03
%
Index- P/E- EPS (ttm)-5.10 Insider Own2.53% Shs Outstand5.02M Perf Week-15.69%
Market Cap15.11M Forward P/E- EPS next Y-5.25 Insider Trans0.00% Shs Float4.89M Perf Month-17.31%
Income-22.91M PEG- EPS next Q-1.00 Inst Own15.23% Short Float1.61% Perf Quarter-61.70%
Sales0.00M P/S- EPS this Y18.18% Inst Trans- Short Ratio2.01 Perf Half Y-82.80%
Book/sh3.81 P/B0.79 EPS next Y-16.67% ROA-78.48% Short Interest0.08M Perf Year-53.69%
Cash/sh2.86 P/C1.05 EPS next 5Y- ROE-97.59% 52W Range2.95 - 44.50 Perf YTD-72.16%
Dividend Est.- P/FCF- EPS past 5Y7.12% ROI-105.92% 52W High-93.24% Beta1.64
Dividend TTM- Quick Ratio6.39 Sales past 5Y1874.16% Gross Margin14.14% 52W Low2.03% ATR (14)0.33
Dividend Ex-Date- Current Ratio6.39 EPS Y/Y TTM-7.21% Oper. Margin0.00% RSI (14)22.27 Volatility8.63% 8.17%
Employees32 Debt/Eq0.17 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price40.00
Option/ShortNo / Yes LT Debt/Eq0.13 EPS Q/Q17.75% Payout- Rel Volume1.03 Prev Close2.95
Sales Surprise- EPS Surprise20.00% Sales Q/Q- EarningsAug 14 AMC Avg Volume39.09K Price3.01
SMA20-14.99% SMA50-45.90% SMA200-67.06% Trades Volume28,696 Change2.03%
Date Action Analyst Rating Change Price Target Change
May-11-21Downgrade Piper Sandler Overweight → Neutral
Aug-26-20Resumed Piper Sandler Overweight
Jan-27-20Initiated Piper Sandler Overweight $3
Jan-24-20Initiated SunTrust Buy
Jan-23-20Initiated SunTrust Buy
Jan-09-20Initiated Aegis Capital Buy $3.50
Jun-26-19Initiated H.C. Wainwright Buy $4
Sep-02-24 09:21AM
Aug-14-24 04:05PM
Aug-07-24 07:00AM
Jun-24-24 08:30AM
Jun-13-24 07:00AM
07:00AM Loading…
May-16-24 07:00AM
May-10-24 01:22PM
12:46PM
May-09-24 04:05PM
May-07-24 08:00AM
May-02-24 07:00AM
Apr-30-24 08:00AM
Apr-03-24 08:30AM
Apr-01-24 02:24PM
Mar-28-24 06:46AM
04:05PM Loading…
Mar-27-24 04:05PM
Mar-25-24 08:00AM
Mar-22-24 12:37PM
09:15AM
06:30AM
Feb-26-24 08:00AM
Feb-20-24 07:30AM
Jan-03-24 07:00AM
Dec-27-23 07:30AM
Dec-21-23 07:30AM
Nov-10-23 01:15PM
Nov-09-23 08:52AM
08:41AM
Nov-08-23 06:42PM
04:05PM
07:30AM Loading…
Nov-07-23 07:30AM
Nov-01-23 07:00AM
Oct-11-23 07:30AM
Sep-28-23 07:00AM
Sep-27-23 07:00AM
Sep-22-23 05:25PM
Sep-21-23 09:35AM
Sep-06-23 07:00AM
Aug-22-23 07:30AM
Aug-10-23 11:05AM
Aug-09-23 04:05PM
Aug-02-23 07:00AM
Jul-26-23 08:00AM
May-11-23 01:44PM
07:30AM
06:30AM
May-10-23 05:15PM
04:05PM
May-03-23 07:00AM
May-02-23 02:16PM
Apr-27-23 06:36PM
Apr-18-23 08:00AM
Mar-18-23 03:12AM
Mar-16-23 05:42AM
Mar-15-23 04:05PM
Mar-08-23 07:00AM
Mar-02-23 07:00AM
Jan-30-23 04:01PM
Jan-23-23 07:00AM
Jan-20-23 10:49AM
Jan-12-23 07:00AM
Nov-02-22 05:55PM
04:02PM
Oct-27-22 07:00AM
Oct-24-22 05:30AM
Oct-21-22 07:48AM
07:00AM
Oct-19-22 07:10AM
Oct-12-22 07:00AM
Sep-21-22 07:00AM
Sep-07-22 07:00AM
Aug-30-22 09:35AM
Aug-11-22 07:45AM
06:30AM
Aug-01-22 07:00AM
Jul-28-22 04:15PM
Jul-25-22 06:30AM
Jun-20-22 09:22AM
May-31-22 07:00AM
May-12-22 07:45AM
06:30AM
May-05-22 07:00AM
May-03-22 07:00AM
Apr-12-22 02:51PM
Apr-11-22 11:52AM
07:00AM
Apr-06-22 07:00AM
Mar-22-22 07:00AM
Mar-16-22 10:00AM
Mar-08-22 06:30AM
Feb-28-22 07:00AM
Jan-25-22 06:30AM
Jan-18-22 07:00AM
Dec-16-21 06:30AM
Dec-06-21 06:30AM
Nov-18-21 07:00AM
Nov-08-21 07:55AM
06:35AM
Nov-02-21 07:00AM
Oct-29-21 03:00PM
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.